( August 20, 2025, 12:28 PM EDT) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on Aug. 19 affirmed a decision from the U.S. Patent Trial and Appeal Board (PTAB) invalidating all challenged claims in a patent related to a glucose sensor for monitoring blood sugar levels, finding no error in PTAB’s prior art analysis....